检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵秋绒 翟向伟[1,2] 赵江龙[1,2] 高大中[3] 杨朴[1,2] 李梅[1,2] 史伟东[1,2] 曹亚斌[1,2] 胡云平[1,2]
机构地区:[1]宝鸡市人民医院 [2]宝鸡市急救中心老年心血管病区,陕西宝鸡721000 [3]重庆医科大学附属第二医院心血管内科,重庆400010
出 处:《中国医学前沿杂志(电子版)》2014年第10期77-80,共4页Chinese Journal of the Frontiers of Medical Science(Electronic Version)
摘 要:目的评估曲美他嗪对心房颤动致心动过速性心肌病患者心功能的影响。方法纳入2011年1月至2013年12月心房颤动致心动过速性心肌病患者63例,随机分为对照组(n=32)和治疗组(n=31),对照组患者采用传统药物治疗,包括β受体阻滞剂、血管紧张素转换酶抑制剂、利尿剂、洋地黄类药物等;治疗组患者在对照组基础上联合盐酸曲美他嗪片(20 mg,3次/天)治疗,疗程为6个月。评价两组患者治疗前后左室功能[左室射血分数(LVEF)]、6分钟步行距离和N末端脑钠肽前体(NT-pro BNP)水平变化。结果治疗6个月后,治疗组患者LVEF[(45.36±6.51)%]、6分钟步行距离[(512.44±180.10)m]、NT-pro BNP水平[(1425.0±1275.0)ng/L]均显著改善,与对照组[(41.25±5.46)%、(435.49±116.17)m、(3150.0±2525.5)ng/L]比较差异均具有显著性(P<0.05)。结论曲美他嗪联合常规药物可明显改善心房颤动致心动过速性心肌病患者的心脏结构和心功能,增加其运动耐量。Objective To review the influence of trimetazidine on exercise tolerance of cardiac function in the patients with tachycardia cardiomyopathy. Method The randomized controlled trials were conducted involving 63 patients heart failure from tachycardia cardiomyopathy; they were randomly divided into control group(n = 32) and test group(n = 31). Patients in control group were administered with routine treatment, such as β receptor blocker, angiotensin converting enzyme inhibitor, diuretic, digitalis. The patients in test group were administered with trimetazidine(20 mg, 3 times each day) based on the routine treatment for 6 months. Left ventricular ejection fraction(LVEF), 6-minute walk test and N-terminal brain natriuretic peptide precursor(NT-proBNP) were conducted to evaluate the therapeutic effect of trimetazidine before and after treatment. Result After treatment, LVEF [(45.36±6.51) %], 6-minute walk test distance [(512.44±180.10) m] and the level of NT-proBNP [(1425.0±1275.0) ng/L] in test group were better than control group [(41.25±5.46) %,(435.49±116.17) m,(3150.0±2525.5) ng/L], the difference was statistical significant(P〈0.05). Conclusion Trimetazidine combined with other conventional drugs can effectively improve the cardiac function of patients with heart failure from tachycardia cardiomyopathy, and increase their physical activity.
分 类 号:R542.2[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222